News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Insmed Incorporated to Hold 2006 Q4 and Year End Earnings Results
March 12, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
RICHMOND, Va.--(BUSINESS WIRE)--Insmed (NASDAQ:INSM) today announced that it will release its 2006 fourth quarter and year end financial results after market close on Wednesday, March 14, 2007.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Insmed Incorporated
MORE ON THIS TOPIC
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
January 14, 2026
·
4 min read
·
Tristan Manalac
Business
JPM26: AstraZeneca’s Path to $80B by 2030 Paved With ADCs, Cell Therapies, Near-Term Launches
January 14, 2026
·
2 min read
·
Tristan Manalac
Layoff Tracker
Lyra Shutters, EMD Serono Downsizes
January 14, 2026
·
44 min read
·
BioSpace Editorial Staff
Podcast
Deals Roll at JPM26, Policy Front and Center, IPOs Are Back, FDA Stays Busy
January 14, 2026
·
2 min read
·
Heather McKenzie
